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Abstract 
Stroke, which is caused by an interruption of blood supply to the brain, is a major public 
health burden because it is one of the leading global causes of death and disability. AMPA 
receptor trafficking is considered to play a vital role in the way cells respond to ischemic stroke, 
but the underlying mechanisms within different brain regions and between male and female 
tissue are still unclear.  
In this study, an acute slice model with a 10 min oxygen-glucose deprivation (OGD) 
challenge was used to induce dramatic energy and oxygen deprivation and simulate ischemic 
stroke. A TTC assay was conducted to measure cellular viability after OGD. Surface expression 
of AMPA receptor subunits, GluA1 and GluA2, was measured under control, or OGD conditions 
to analyze the pattern of AMPA receptor trafficking. To examine the possible region and sex 
differences, slices from different brain regions (septal hippocampus vs. temporal hippocampus vs. 
motor cortex) of each sex were collected. The data were analyzed using a two-way factor, mixed 
model ANOVA.  
According to the TTC assay results, after a 3 h recovery following 10 min OGD, 
metabolism decreased in all groups, but there was no significant interaction effect between sex 
and region (p = 0.84, F(2,48) = 0.17), and no significant main effect of region (p = 0.34, F(2,48) = 
1.11), or sex (p = 0.62, F(1,48) = 0.24). Similarly, the immunoblot results showed no sex-region 
interaction (GluA1: p = 0.41, F(2,21) = 0.93; GluA2: p = 0.11, F(2,21) = 2.40) and no significant 
main effect of region (GluA1:	  p = 0.91, F(2,21) = 0.096; GluA2:	  p = 0.98, F(2,21) = 0.020), or sex 
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(GluA1:	   p = 0.21, F(1,21) = 1.71; GluA2: p = 0.14, F(1,21) = 2.33), on GluA subunit surface 
expression after OGD. In addition, based on the calculated effect sizes (partial eta-squared, ηp2), 
none of the differences could be regarded as notable (ηp2	  = 0.14 indicates a large magnitude of 
effect). 
In summary, metabolic function and surface expression of GluA1 and GluA2 were not 
significantly different between cortical and hippocampal slices, or between male, or 
female-derived slices, following a 10 min OGD challenge.  
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1. Literature Review  
Stroke is caused by an interruption of blood supply to the brain. The reduced blood supply 
dramatically induces energy and oxygen deprivation, which can lead to cell death and severe 
brain dysfunction. While interruption of blood flow to the brain can be triggered by either a 
blood clot (ischemic), or a vessel rupture (hemorrhagic), about 87% of strokes are ischemic 
(American Heart Association, 2017). Notably, the symptoms of stroke, including one-sided 
motor impairment, aphasia, and hemianopsia (Donnan et al., 2008), usually occur right after the 
onset of stroke and can be transient, or permanent.  
1.1 Public health burden of stroke 
Because of its severe consequences, stroke is one of the leading global causes of death and 
disability. In 2015, an estimated 6.7 million people died from stroke, accounting for 12% of all 
global deaths (World Health Organization, 2017). In addition, stroke is the second leading global 
cause of disability, resulting in 5 million people being permanently disabled every year (World 
Health Organization, 2017). In 2013, 102 million stroke-related disability adjusted life years 
(DALYs) were estimated to have been lost globally (Feigin et al., 2016). According to an 
estimate from the World Health Organization (Mendis et al., 2011), the enormous global burden 
of stroke will likely increase over the following decades in developing countries, and will be a 
major challenge to public health systems. In Canada, stroke also brings a heavy burden to society 
and family. According to a prevalence study (Krueger et al., 2015), in 2013, more than 400,000 
Canadian patients were struggling with impairments caused by stroke, which costs more than 3.6 
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billion CAD annually (Ontario Stroke Network, 2016). As a result, understanding the underlying 
cellular mechanisms of stroke is urgent. 
Although stroke can occur at any age, almost three-fourths of strokes occur in people over 
the age of 65 (Ontario Stroke Network, 2016). Aging is one of the most important risk factors of 
stroke, and the incidence rate of stroke increases rapidly after the age of 55 (Ontario Stroke 
Network, 2016). In addition, noticeable sex differences exist in stroke, which is 25% more likely 
to occur among men (Ontario Stroke Network, 2016; Stroke.nih.gov., 2017). Other risk factors 
for stroke include hypertension, smoking, obesity, hypercholesterolemia, and previous stroke 
(Donnan et al., 2008), all of which are highly related to unhealthy diet, low physical activity 
level, tobacco use, and alcohol intake (World Health Organization, 2017). 
1.2 Current treatment and prevention strategies  
To relieve the burden of stroke, current clinical practice has shown that rapid treatment of 
recombinant tissue plasminogen activator (rtPA), such as alteplase, can significantly improve 
health outcomes after the onset of stroke (National Institute of Neurological Disorders and 
Stroke rt-PA Stroke Study Group, 1995; Atlantis, 2004; Hacke et al., 2008). However, the 
consensus on the safe and efficient therapeutic window for stroke is between 3 to 4.5 hours 
(Atlantis, 2004; Hacke et al., 2008; Paciaroni et al., 2009; Powers et al., 2018). As a result, if 
stroke occurs, prompt treatment is necessary to minimize brain damage. However, prompt 
treatment is challenging because a brain scan and other test procedures, such as noninvasive 
vascular imaging tests, are required to confirm the type of stroke before treatment. According to 
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the latest guidelines (Powers et al., 2018), brain-imaging tests are recommended to be completed 
within 20 minutes of patient arrival. For patients who are not suitable for the rtPA treatment, 
another emerging treatment strategy for stroke is endovascular therapy, which is a microcatheter 
inserted to remove blood clots and release drugs (Sacks et al., 2013). 
As the clinical treatment is highly time dependent, the demand on medical resources is high. 
To balance the cost and benefit of stroke management, it is also important to include the public 
health prevention system. Current primary prevention strategies focus on the control of risk 
factors, such as dietary modification, control of tobacco use, and the administration of prevention 
drug therapy, such as thrombolysis, to high-risk populations (Donnan et al., 2008). At the same 
time, to reduce the	   incidence and severity of recurrent stroke, secondary prevention is designed 
to be implemented during the recovery period to manage risk factors (Wein et al., 2018). For 
example, application of thrombolysis, such as aspirin treatment, can reduce the risk of disability 
after stroke in some conditions (Hackam & Spence, 2007; Wein et al., 2018). Furthermore, 
stroke rehabilitation, a tertiary strategy, may be applied for stroke recovery. In Canada, every 
year around 6500 patients are screened for in-patient stroke rehabilitation for a median of 30 
days following stroke onset, and then delivered to long-term care through outpatient services 
(Hebert et al., 2016). 
To consummate the current treatment and prevention framework of stroke, further 
understanding of stroke mechanisms and more evidence-based approaches are needed. 
According to the guidelines for the prevention of stroke and transient ischemic attack (Kernan et 
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al., 2014), the benefits of weight loss among patients with an ischemic stroke and obesity are 
unclear. Also, while the application of prevention treatments, such as statins (Odden et al., 2015) 
and angiotension receptor antagonists (Chen et al., 2015), are cost-effective for the primary 
prevention of stroke, the benefits can be counteracted by an increase of geriatric-specific adverse 
effects, such as muscle-related aches and liver-enzyme abnormalities (Armitage et al., 2019; 
Schiattarella et al., 2012; Scott et al, 2009). Finally, the average first year inpatient rehabilitation 
cost from 2001 to 2005 was $17,081 in the US (Godwin et al., 2011), which is a burden to both 
stroke survivors and health systems. Given currently overwhelmed health systems and limited 
medical resources, more effective and efficient secondary prevention and treatment strategies are 
required to cope with stroke and its related brain damage. 
1.3 Pathophysiology of ischemic stroke  
As about 87% of strokes are ischemic (American Heart Association, 2017), it is vital to 
understand the pathophysiology of ischemic stroke. Ischemic stroke is induced by the 
interruption of blood supply, which reduces the energy and oxygen available to the brain. If the 
deprivation occurs among wide areas of brain, stroke is classified as global ischemia; if the 
deprivation occurs only in a specified region, it is focal ischemia (Siesjö et al., 1995). Typically, 
focal ischemia is less severe. Although the ischemic center undergoes irreversible necrosis,	   the	  
penumbral regions surrounding the occluded artery are potentially salvageable, as biochemical 
cascades leading to selective cell death can be triggered in this area (Siesjö et al., 1995; Siesjö, 
1992; de Lores Arnaiz & Ordieres, 2014).  
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1.3.1 Ischemic cascade 
The ischemic cascade is a series of biochemical events triggered by the onset of ischemia. 
The brain requires a consistent supply of oxygen and glucose to retain normal function 
(Mergenthaler et al., 2013; McIlwain et al., 2013). The brain cannot store a large amount of 
energy, and heavily relies on aerobic metabolism (Mergenthaler et al., 2004), so that, during an 
ischemic stroke, the brain suffers a rapid decrease of ATP. As a result, the ATP-dependent ion 
transport pumps fail, and the electrochemical gradients are damaged, which can induce 
membrane depolarization (Scheiner-Bobis, 2002). The failure of the Na+/K+ pump, a crucial ion 
transporter maintaining a high intracellular K+ level and a low intracellular Na+ level, will lead to 
an increase of intracellular Na+ and activation of the Na+/Ca2+ exchanger, which will accelerate 
the accumulation of intracellular Ca2+ (de Lores Arnaiz & Ordieres, 2014; ScheinerBobis, 2002). 
Next, the influx of calcium ions can trigger the release of neurotransmitters, such as glutamate 
and aspartate, from presynaptic terminals (Weilinger et al., 2013). The increased concentration of 
extracellular glutamate can lead to the opening of many ionotropic transmembrane receptors, 
such as N-methyl-D-aspartate (NMDA) receptors and α-amino-3-hydroxy-5-methyl-4- 
isoxazolepropionic acid (AMPA) receptors (Weilinger et al., 2013; Szydlowska & Tymianski, 
2010), which will further induce the influx of calcium ions. The excess internal concentration of 
calcium ions overactivates a range of cellular signaling pathways and leads to the production of 
free radicals and calcium-dependent enzymes, which can break down cell membranes and lead to 
cell death in a process called excitotoxicity (Szydlowska & Tymianski, 2010). As well, 
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mitochondria, vital organelles regulating cell survival, play an important role in cellular calcium 
signaling, and impairments of mitochondrial respiration caused by injury can depolarize the 
mitochondrial membrane potential leading to excessive release of calcium ions and contribute to 
the cascade of neuronal death after ischemic stroke (Szabadkai & Duchen, 2008;	  Kirichok et al., 
2004). 
One possible pathway induced by the influx of calcium ions is the activation of neuronal 
nitric oxide synthase (NOS), leading to the production of the free radical nitric oxide (NO) 
(Johnston et al., 2011; Forstermann & Sessa, 2011). NO can form a complex with superoxide, 
leading to toxic peroxynitrite molecules that can add nitrate to tyrosine groups on proteins and 
contribute to the production of hydroxyl radicals, which cause lipid peroxidation of proteins and 
DNA (Johnston et al., 2011; Cherubini et al., 2005). Nitric oxide can also disrupt the function of 
cytochrome oxidase, and increase production of superoxide and peroxynitrite ions in 
mitochondria, which is harmful to mitochondrial respiration (Taylor & Moncada, 2010; Johnston 
et al., 2011). According to another possible pathway, calcium ions entering through NMDA 
receptors can activate calpain, a protease that can degrade cell structure and induce further 
apoptosis (Stys & Jiang, 2002). In addition, the activated calpain can also trigger caspase-3 
involved apoptosis execution (Schwab et al., 2002; Johnston et al., 2011). Overall, the influx of 
calcium and release of glutamate will induce various cell signaling events that may lead to cell 
death. 
After focal cerebral ischemia, the cells immediately surrounding the site of blood 
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interruption usually die through necrosis (Hakim, 1998). The penumbra, however, suffers less 
serious energy deficiency and experiences milder damage (Hakim, 1998; Broughton et al., 2009; 
Bonfoco et al., 1995), so that a progressive apoptotic cascade is triggered. The different types of 
cell death, apoptosis and necrosis, indicate that although the penumbra is also under the threat 
after ischemia, it is potentially recoverable and thus well worth the exploration of therapeutic 
intervention (Hakim, 1998; Broughton et al., 2009). 
1.3.2 Glutamate receptors 
Glutamate is the most important excitatory neurotransmitter in the brain. Glutamate 
receptors are widely located on postsynaptic membranes, and mediate the vast majority of 
postsynaptic excitation (Traynelis et al., 2010; Lau & Tymianski, 2010). Glutamate receptors can 
be divided into ionotropic and metabotropic classes. In recent decades, ionotropic glutamate 
receptors (iGluRs), such as NMDA receptors and AMPA receptors, have been widely studied 
(Traynelis et al., 2010; Lau & Tymianski, 2010). 
The heterotetrameric NMDA receptor contains two obligatory GluN1 subunits and two 
GluN2 subunits, each of which has an extracellular N-terminal domain and an intracellular 
C-terminal domain (Paoletti et al., 2013). Currently, there are four different GluN2 subtypes 
thought to exist (GluN2A-D) (Lau & Tymianski, 2010). The distribution of the four GluN2 
subunits varies, with GluN2A widely distributed in the brain, GluN2B primarily distributed in 
the forebrain, GluN2C primarily distributed in the cerebellum, and GluN2D primarily distributed 
in the thalamus (Lau & Tymianski, 2010). In addition, the level of GluN2B is higher in postnatal 
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brain, but the level of GluN2A exceeds that of GluN2B during development (Johnston et al., 
2011). The higher level of GluN2B is thought to be related to the greater learning abilities at 
childhood (Liu et al., 2004). However, the higher level of GluN2B is also one possible reason for 
the different vulnerability of brain at different ages, as NMDA channels with a larger portion of 
GluN2B subunits open more easily and stay open longer (Johnston et al., 2011). 
AMPA receptors are formed by four types of subunits, GluA1-4, each of which has an 
extracellular N-terminus and intracellular C-terminus (Henley & Wilkinson, 2016; Wright & 
Vissel, 2012). As most AMPA receptors are heteromers containing GluA1/GluA2, or 
GluA2/GluA3 (Lu et al., 2009), the existence of GluA2 is responsible for regulating excitatory 
synaptic transmission by controlling the influx of calcium and sodium ions (Man, 2011). The 
GluA2 subunit inhibits the AMPA receptor’s calcium permeability, which helps to maintain the 
low intracellular calcium concentration at basal conditions in mature neurons, because of the 
selectively targeted Q/R site editing (Man, 2011; Wright & Vissel, 2012; Whitney et al., 2008). 
In contrast, the presence of GluA2-lacking AMPA receptors will lead to increasing calcium 
permeability and further excitotoxicity (Koszegi et al., 2017).  
Ischemia is thought to affect GluA2 levels in cultured hippocampal neurons by inducing a 
rapid endocytosis of GluA2, resulting in a switch to GluA2-lacking calcium permeable AMPA 
receptors (Blanco-Suarez & Hanley, 2014; Koszegi et al., 2017). The existence of GluA2-lacking 
calcium permeable AMPA receptors can induce the influx of calcium ions and further plasma 
membrane injuries (Farber, 1990; Man, 2011; Henley & Wilkinson, 2016; Wang et al., 2012). As 
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a result, during ischemia, dysregulated GluA2-lacking AMPA receptors can induce excessive 
calcium influx and cause excitotoxicity (Man, 2011; Henley & Wilkinson, 2016; Wang et al., 
2012). 
1.3.3 AMPA receptor trafficking  
The movement of receptors to, or from, the cell surface is known as receptor trafficking. 
Receptor trafficking can regulate the density of postsynaptic receptors and adjust the efficiency 
of response to the release of neurotransmitters (Bedford, 2009). The dynamically regulated 
GluA2-lacking AMPA receptor distribution is also considered the result of receptor trafficking 
(Tanaka et al., 2000; Pellegrini-Giampietro et al., 1997). For example, according to neuronal cell 
culture studies, under basal conditions, most GluA2-lacking AMPA receptors are located at 
presynaptic sites, or endosomes (Hanley, 2014). When stimulation, such as the influx of calcium 
ions, is applied, GluA2-lacking AMPA receptors are rapidly expressed at the surface of 
postsynaptic neurons (Hanley, 2014;). Regulation of this process requires post-translational 
modifications. Phosphorylation and de-phosphorylation are the most widely studied 
modifications, and can regulate endocytosis by changing the binding affinity of trafficking 
adaptors (Bedford, 2009). For example, phosphorylation can increase the interaction of AMPA 
receptors with scaffolding	  and cytoskeleton proteins (Derkach et al., 2007). Furthermore, some 
studies have examined the influence of tyrosine phosphorylation of GluA2 in AMPA receptor 
trafficking and plasticity. For example, Y876 phosphorylation of GluA2 will downregulate the 
endocytosis of GluA2	   and prevent the internalization of AMPA receptors during long-term 
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depression (LTD) induction (Lu & Roche, 2012). 
Oxygen-glucose deprivation (OGD), which causes excitotoxicity and delayed cell death due 
to the extracellular accumulation of excessive glutamate (Beattie, 2000), may alter the surface 
expression of AMPA receptors. In a basal state, the main synaptic AMPA receptors are GluA1/2 
and GluA2/3 heteromers (Jaafari et al., 2012). After OGD, however, internalization of GluA2 
subunits can be observed in cultured hippocampal neurons, and leads to the increased surface 
expression of GluA2-lacking, Ca2+-permeable AMPA receptors (Blanco-Suarez & Hanley, 2014; 
Liu et al., 2006). The GluA2-lacking AMPA receptors allow calcium influx and are essential to 
OGD-induced cell death in hippocampal neurons (Blanco-Suarez & Hanley, 2014; Liu et al., 
2006).  
One possible factor regulating the surface expression of AMPA receptors after OGD is the 
internalization of GluA2-containing AMPA receptors (Beattie, 2000). According to in vitro data, 
administration of excess glutamate can induce rapid internalization of GluA2-containing AMPA 
receptors (Beattie et al., 2000). After OGD, the initial rapid phase (calcium influx through 
NMDA receptors) induces GluA2-lacking AMPA receptor insertion, and a later phase reduces 
GluA2 subunit expression by downregulating its mRNA expression (Malenka, 2003; Hayashi et 
al., 2000; Blanco-Suarez & Hanley, 2014).  
In addition, phosphorylation can directly regulate the electrophysiological, structural, and 
biochemical properties of AMPA receptors, and is vital for synaptic plasticity (Lu & Roche, 
2012; Zhang et al., 2013). The phosphorylation level of AMPA receptors can be altered after 
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ischemia, and can further affect surface expression of AMPA receptors (Carvalho et al., 2000; 
Zhang et al., 2013). According to Lu & Roche (2012), subunits can be phosphorylated on 
tyrosine residue 876 (Y876) by protein kinases such as CaMKII, PKA, and PKC, and the 
phosphorylation level of the GluA1 subunit in the rat hippocampal CA1 region is increased after 
ischemia, which may be mediated by activated CaMKII (Fu et al., 2004; Takagi et al., 2003).	    
1.4 Regional differences in the effect of ischemia 
In general, regions with higher demand of energy, or those located in vascular border areas 
are more vulnerable to injuries like ischemia (Cervos-Navarro & Diemer, 1991). In addition, 
cellular differences, such as the distribution of glutamate receptors, can influence robustness due 
to the alteration of calcium ion permeability. According to previous studies, the hippocampus, 
which plays a vital role in memory formation and spatial awareness (Bannerman et al., 2004), is 
very sensitive to ischemic injury (Schmidt-Kastner & Freund, 1991). In particular, CA1	  
pyramidal neurons in the hippocampus are more vulnerable than CA3	  pyramidal neurons to brain 
injury, such as that caused by ischemia (Busl & Greer, 2010; Lalonde & Mielke, 2014; Koszegi 
et al., 2017). The subfield difference may be mediated by the decrease of synaptic AMPA 
receptors (e.g., both GluA1 and GluA2) after OGD in CA3 pyramidal neurons, but not in CA1 
pyramidal neurons (Dennis et al., 2011). 
1.4.1 Differences across the longitudinal axis of the hippocampus 
Furthermore, some studies have realized the anatomical and functional differences within 
the hippocampal structure, along the longitudinal axis (Fanselow & Dong, 2010; Nguyen et al., 
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2015; Diniz et al., 2016; Floriou-Servou et al., 2018; Zhang et al., 2018; Gulyaeva, 2018). 
Generally, the septal (or dorsal) and temporal (or ventral) poles are regarded as two distinct 
regions with different physiologic functions (Bekiari et al., 2015). The septal pole is thought to 
be more linked to cognitive functions (Moser et al., 1995), whereas the temporal pole is thought 
to be more related to the regulation of stress and emotion (Henke, 1990; Fanselow & Dong, 
2010).  
Since the 1980s, different brain injury levels between the septal and temporal poles within 
the hippocampus after ischemia have been noticed (Smith et al., 1984; Ashton et al., 1989). 
Some studies have shown that the CA1 region in the septal pole is more vulnerable to ischemia 
than the same region in the temporal pole (Ashton et al., 1989). One possible reason may be the 
high cerebral blood flow (CBF) in the temporal CA1 region (Ashton et al., 1989). In addition, the 
septal CA1 region contains a higher density of pyramidal neurons, which may reduce the 
glia/neuron ratio and lead to higher susceptibility to ischemia (Ashton et al., 1989). 
However, some studies have reached a different conclusion. For example, it was observed 
from electrophysiological data that neurons in the temporal pole were intrinsically more 
excitable than those in the septal pole (Papatheodoropoulos & Kostopoulos, 2000; Dougherty et 
al., 2012). According to Papatheodoropoulos and Kostopoulos (2000), increasing calcium ions 
from a basal level to 5 mM induced an enhancement of baseline CA1 field excitatory 
postsynaptic potentials (EPSP) only in temporal hippocampal slices, which indicates that the 
temporal hippocampus is more excitable and has a higher neurotransmitter release probability. In 
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addition, Onufriev et al. (2017) found that after ischemia, corticosterone was released in the 
temporal pole, but not in the septal pole, which indicates the possibility of different 
neuroinflammation mechanisms between the two regions. As a result, it is likely that the 
vulnerability to OGD varies along the longitudinal axis (Rami et al., 1997; Czerniawski et al., 
2009; Fanselow and Dong, 2010; Isaeva et al., 2015; Strange et al., 2014; Bekiari et al., 2015; 
Floriou-Servou et al., 2018), but the phenomenon and potential mechanisms are not fully 
understood.  
1.4.2 Differences between hippocampus and cortex 
Cortical neurons (Blanco-Suarez & Hanley, 2014; Schmidt-Kastner & Freund, 1991), which 
affect musculoskeletal control, perception, memory, cognition, awareness, language, and 
consciousness (Siegelbaum & Hudspeth, 2000), appear to be more robust to ischemic injury than 
hippocampal neurons (Blanco-Suarez & Hanley, 2014). An in vivo rat acute hypoxia experiment 
showed that the mitochondrial respiratory rate decreased in hippocampal mitochondria, but not 
in cortical mitochondria due to differences in NO metabolism and membrane potential change 
patterns (Czerniczyniec et al., 2015). In addition, evidence also suggests that the regional 
differences may be caused by different AMPA receptor trafficking patterns. Work done with 
neuronal cultures after OGD (Blanco-Suarez & Hanley, 2014; Koszegi et al, 2017) shows that 
rapid internalization of the GluA2 subunit exists in hippocampal neurons, but not in cortical 
neurons, which may be mediated by the hippocampal specific PICK1-dependent synaptic 
expression of GluA2-lacking AMPA receptors (Koszegi et al, 2017; Jaafari et al., 2012). 
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1.5 Sex differences in ischemia 
The presence and potential mechanism of sex differences after OGD have been well 
discussed in recent decades. The incidence of clinical stroke is higher in men until 85 years of 
age (Manwani and McCullough, 2011). Generally, male brain is thought to be more vulnerable 
to ischemia than female brain in both animal and clinical studies (Reeves et al., 2008; Liu et al., 
2009; Cheng and Hurn, 2010; Manwani and McCullough, 2011). The sex difference is usually 
thought to be related to the effects of hormones,	  but	  hormone-independent intrinsic factors have 
been discussed in recent decades as well (Gibson, 2013).  
Generally, the effects of estrogens are considered neuroprotective (Manwani & McCullough, 
2011). Female rats were observed to have a more severe infarct and higher cognitive 
impairments after the removal of ovaries (Cai et al., 2014), and this effect could be reversed by 
the supplement of exogenous estrogen in middle-aged female rats (De Butte-Smith et al., 2009). 
One possible beneficial effect of estrogen may be the estrogen receptor (ER) mediated inhibition 
of NADPH oxidase, which can reduce the ischemic damage (Zhang et al, 2009). In addition, 
some studies have revealed that the distribution of ERs varies along the longitudinal axis of the 
hippocampus, with more ERs within GABAergic neurons in the septal pole, which may cause 
different neuroprotective effects between septal and temporal hippocampus (Hart et al., 2001).  
The effect of testosterone is still controversial, and tends to be dose- and age- dependent 
(Uchida et al., 2009;	   Kim & Vemuganti, 2015). Some experiments have revealed that 
testosterone supplements can worsen infarct size after ischemia by regulating transcription of 
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inflammatory genes (Cheng et al., 2007; Hawk et al. et al., 1998), however, other studies have 
indicated that testosterone application can be neuroprotective by relieving oxidative stress 
(Ahlbom et al., 2001;	  Fanaei et al., 2014). A possible explanation of the dimorphic effect was 
revealed by a study (Uchida et al., 2009) indicating that low doses of testosterone can help mice 
brain recover after ischemia, but high doses of testosterone can cause an inverse effect. 
Importantly, hormones cannot fully explain the sexually dimorphic patterns after ischemia, 
as sex differences also exist among preadolescents and the elderly (Du et al., 2004; Gibson, 
2013). Intrinsic factors other than hormones, such as sex chromosomes, may be relevant. 
According to one cell viability study using cultured neurons, XY neurons after excitotoxicity are 
more sensitive than XX neurons, because of the inability of XY neurons to maintain intracellular 
levels of glutathione (a substance that can reverse excitotoxic brain injury) (Du et al., 2004). 
Some other sex-dependent molecule alterations involved in post-ischemia cell death are also 
found to not be influenced by hormone changes (Gibson, 2013). For example, neuronal nitric 
oxide synthase (nNOS), which regulates cell death after ischemia, is male toxic and female 
protective, by increasing infarction in male mice, but protecting female mice after middle 
cerebral artery occlusion (MCAO) (McCullough et al, 2005). However, the dimorphic effect of 
nNOS cannot be influenced by changing hormone exposure (Gibson, 2013).   
	   16	  
2. Study Rationale  
As regional differences after ischemia have been examined in cultured neurons 
(Blanco-Suarez & Hanley, 2014), but not in tissue slices, the study aimed to explore the effect of 
an established in vitro model of ischemia (OGD, oxygen-glucose deprivation) on tissue slices 
prepared from rat hippocampus and motor cortex. In addition, possible sex differences after 
ischemia were examined in this model by using tissue slices from both male and female rats. 
Lastly, variability in OGD-mediated AMPA receptor trafficking was explored by comparing the 
surface expression of GluA2-lacking AMPA receptors across slices from each condition. 
In this study, I expected to answer the following questions: 
1. Does brain region affect outcome in our OGD model? In particular, are hippocampal 
slices more vulnerable to OGD than cortical slices, and, within the hippocampus, is the 
septal pole more vulnerable to OGD than the temporal pole? 
2. Does a sex difference exist in our OGD model? Specifically, do male and female brain 
slices react differently to OGD? 
3. Does OGD alter the surface expression of GluA2? If so, is there a difference in 
OGD-mediated trafficking as a function of either brain region, or animal sex? 
Given what has been reported in the literature, brain region and sex were expected to 
influence slice viability (Cervos-Navarro & Diemer, 1991; Fanselow & Dong, 2010; Gibson, 
2013; Lalonde & Mielke, 2014; Kim & Vemuganti, 2015; Floriou-Servou et al., 2018). Based on 
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the literature and previous work from our laboratory, sexual dimorphism was expected, and male 
slices were hypothesized to be more sensitive to OGD. Furthermore, different regions of the rat 
brain were expected to react differently after OGD. Specifically, the hippocampal slices were 
expected to be more vulnerable than motor cortex slices, and within the hippocampus, the septal 
pole slices were expected to be more vulnerable than the temporal pole slices. Along with these 
regional and sex differences in viability, the surface expression of GluA2 was expected to 
decrease in a manner that paralleled slice viability.  
To examine slice viability after OGD, a 2,3,5- Triphenyltetrazolium Chloride (TTC) Assay 
was used to measure mitochondrial function (Lalonde & Mielke, 2014). In addition, to determine 
GluA2 surface expression among the different sample groups, Sulfo-NHS-SS-biotin (Blanco- 
Suarez & Hanley, 2014) was used to label surface expressed proteins, and the amount of targeted 
surface GluA2 subunits was identified with SDS-PAGE and immunoblotting. 
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3. Methods  
3.1 Animals 
All experiments followed procedures approved by the animal care committee at the 
University of Waterloo. Male and female, non-sibling Sprague-Dawley rats (weight 250-350 g) 
were received as young adults and housed in polypropylene cages with woodchip bedding and 
stainless steel wire lids. Animals were allowed free access to water and standard rodent chow 
(Teklad rodent diet) and were kept on a 12-hour dark/light cycle in groups of 3 rats per cage. 
3.2 Dissection and slice preparation  
Before dissection, each rat was anaesthetized in a CO2 induction chamber and then 
decapitated. Brains were then quickly extracted and placed in 4°C oxygen-rich (95% O2: 5% CO2) 
artificial cerebrospinal fluid (ACSF; composed of 127.0 mM NaCl, 2.0 mM KCl, 1.2 mM 
KH2PO4, 26.0 mM NaHCO3, 2.0 mM MgSO4, 2.0 mM CaCl2, 10.0 mM glucose; pH 7.37-7.43; 
300-320 mOsm; reagents purchased from Sigma Aldrich Canada Co.).  
To collect samples for the TTC assay (see section 3.4), or biotinylation (see section 3.5), 
both hippocampus and motor cortex slices were needed. After dissection,	  to	  collect	  slices	  from	  
motor	  cortex,	  a whole brain mould (Ted Pella, Inc., Redding, CA, USA) for adult rats was used 
(Thacker et al., 2019). The mould was submerged in chilled ACSF. A razor blade was then 
placed at position 6 to remove the prefrontal cortex. Next, a mid-sagittal cut was made to 
separate the hemispheres. To collect hippocampal slices,	   the hippocampus from the right 
hemisphere was extracted in a Petri dish filled with chilled ACSF, and tissue slices (350 µm) 
	   19	  
were prepared with a McIlwain tissue chopper (Mickle Laboratory Engineering Co., Surrey, UK).	  
From each hippocampus, six septal slices were collected, two intermediate slices were discarded, 
and six temporal slices were collected. The first, third, and fifth hippocampal slices were 
assigned to the control group and the second, fourth, and sixth slices were assigned to the OGD 
group (Figure 7.1 A; Figure 7.1 B; Figure 7.2). The left hemisphere was assigned to be sectioned 
coronally with a McIlwain tissue chopper	  to provide six motor cortex slices (350 µm), including 
the area encompassed by plates 9-21 in the Paxinos and Watson atlas (Paxinos and Watson, 2017; 
Thacker et al., 2019; Figure 7.1 C; Figure 7.2), with the same assignment rule for the control and 
OGD groups. 
3.3 The OGD model 
All slices were placed on inserts containing a semi-permeable membrane, and held at 
interface in an incubation chamber with oxygen-rich ACSF (35°C ± 0.5°C) for 90 min after 
slicing. Inserts containing the OGD group slices were transferred to a 35°C ± 0.5°C 
oxygen-glucose deprivation environment for 10 min (Lalonde & Mielke, 2014). To ensure 
oxygen-glucose deprivation, the 10 mM glucose in the normal ACSF was replaced by 10 mM 
sucrose and the solution was gassed with nitrogen (N2) in a 35°C water bath for at least 60 min 
prior to use. To control for any stress introduced by the manipulation, the control group slices 
underwent a SHAM procedure in which they were moved within the chamber containing normal 
ACSF. After the 10 min OGD challenge, or SHAM procedure, all slices intended for the TTC 
assay were maintained in a 35°C ± 0.5°C oxygen-rich ACSF environment for a 3-hour recovery 
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period, and all slices intended for the biotinylation assay were immediately processed (Figure 
7.3). 
3.4 TTC assay  
The 2,3,5- triphenyltetrazolium chloride (TTC) assay can be used to distinguish cellular 
metabolic activity levels because the dehydrogenases in metabolically active cells can reduce 
colorless TTC into a deep red 1,3,5- triphenylformazan (TPF) (Preston & Webster, 2000; 
Lalonde & Mielke, 2014). As a result, the TTC assay was performed for each set of slices to test 
metabolic activity. After a 3-hour recovery from OGD, or SHAM, each group of slices was 
incubated with 2 mL 2% (w/v) TTC solution (2,3,5- TTC powder freshly dissolved in ACSF, 
gassed with N2 for 5 min) for 1 h at 35°C ± 0.5°C, under lucifugal conditions. Next, slices were 
rinsed twice with ACSF that had been gassed with N2, the metabolites were extracted with 1.5 
mL extraction buffer (DMSO: 95% EtOH = 1:1) overnight, and the absorbance was detected at 
485 nm with a spectrophotometer (Figure 7.3). 
3.5 Biotinylation  
Biotinylation is a method to study surface expression and trafficking of receptors 
(Blanco-Suarez & Hanley, 2014). After the 10 min OGD challenge, 100 µL 10 mM 
Sulfo-NHS-SS-Biotin (dissolved in chilled ASCF) was separately applied to each tissue slice for 
45 min at 4°C in darkness to allow for interaction with surface proteins. After 3 rinses with 
quenching buffer (TBS; 25 mM Tris, 0.15M sodium chloride; pH 7.2), excess biotin was washed 
away, and the surface portion labeled by biotin was ready for the protein assay and bead 
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conjugation (Figure 7.3; Figure 7.4). 
3.6 Protein assay 
After biotinylation, to collect samples for the immunoblotting experiments, each group of 
slices was transferred to a 2 mL glass homogenizing tube with 350 µL of chilled non-ionising 
lysis buffer (composed of 100 mM NaCl, 25 mM EDTA, 10 mM Tris, 1% (v/v) Triton X-100, 1% 
(v/v) IGEPAL CA-630), supplemented with sodium orthovanadate and a protease inhibitor 
cocktail (AEBSF, Aprotinin, Bestatin hydrochloride, E-64, Leupeptin hemisulfate salt, Pepstatin 
A). The slices were manually homogenized with a PTFE pestle and then centrifuged at 1000 × g 
for 10 min at 4°C. Supernatants were collected for future immunoblot analysis.  
Before being stored at -80°C, the concentration of each sample was measured by a DC 
protein assay kit (BioRad Laboratories, Inc., CA, USA). A linear standard set was freshly 
prepared with albumin (BSA) dissolved in non-ionising lysis buffer. The standard concentration 
gradient was typically 0, 0.25, 0.5, 1, 1.25, 1.5, 1.75, 2 µg/µL. The freshly prepared linear BSA 
standards, as well as each sample were placed into a 96-well plate in triplicate to complete 
reactions with reagent A’ (composed of 20 µL reagent S and 1000 µL reagent A) and reagent B 
from the kit, so that the optical density of each unknown sample group could be measured and 
averaged	  by	  spectrophotometry (at 750 nm). 
3.7 SDS-PAGE and immunoblot analysis  
Before conducting SDS-PAGE, 80 µL of Neutravidin beads were washed three times with 
500 µL of non-ionising lysis buffer and then incubated with each sample group to target 
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biotin-labeled surface proteins. After a 4 h incubation with 100 µg total protein sample at 4°C on 
a rotator, the mixtures were spun and washed three times with 500 µL of non-ionising lysis 
buffer; after each wash, samples were spun at 10,000 × g for 30 s at 4°C. The sediment, with the 
bead-biotin-protein complexes, contained the surface proteins needed for further electrophoresis 
and immunoblot analysis (Figure 7.3). 
SDS-PAGE was applied to separate the protein samples based on molecular weight. For 
protein separation, 10-well 10% gels were freshly prepared. All samples were prepared with 1× 
sample buffer (composed of 34.9 mM Tris-HCl (pH 6.8), 13.15% (w/v) glycerol, 1.05% SDS, 
0.005% bromophenol blue), and were heated at 95°C for 5 min. The samples were separated in 
running buffer (composed of 3.0 g/L Tris base, 14.4 g/L glycine, and 1.0 g/L of SDS; pH 8.3) at 
220 V for 1 h, and were then wet-transferred onto polyvinylidene fluoride (PVDF) membranes in 
transfer buffer (composed of 25 mM Tris, 192 mM glycine, 20% (v/v) methanol; pH 8.3) at 350 
mA, 4°C for 2 h. Each sample was run in duplicate and averaged for statistical analysis later. A 
Ponceau S image (which revealed the total amount of protein present in each lane of the blot) 
was used as a confirmation of successful transfer and an internal control for loading variability 
(Thacker et al., 2016). 
Before application of antibodies, membranes were blocked with 5% milk (w/v) made in 
chilled TBST (composed of 20 mM Tris, 140 mM NaCl, 01% (v/v) Tween-20; pH 7.6) for 1 h. 
The level of target proteins was detected with corresponding primary and secondary antibodies. 
The blots were then incubated with primary antibody overnight at 4°C, and then with secondary 
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antibody for 1 h at room temperature. The GluA1 (rabbit, in 5% milk, 1:1,000, Cell Signaling,	  
Danvers, MA, USA) and GluA2 (rabbit, in 5% milk, 1:1,000, Cell Signaling, Danvers, MA, 
USA) primary antibodies were tested and compared among different conditions. The 
corresponding secondary antibody was anti-rabbit (1:2,500, in 5% milk, IgG, Cell Signaling, 
Danvers, MA, USA). The antibody combinations were detected by digital camera with	  
electrochemiluminescence (ECL) from Crescendo (Immobilon Crescendo western HRP substrate; 
Millipore). 
3.8. Statistical analysis  
3.8.1 Software  
All data were stored in Microsoft Excel worksheets and analyzed by GraphPad Prism 
(Verision 6.00) and R (Version 3.1.1). All the images were generated by GraphPad Prism 
(Verision 6.00) and the statistical significance was set at p ≤ 0.05. 
3.8.2 Data exclusion criteria  
Before statistical analysis, outliers were identified and excluded from the data set via 
Tukey’s rule (Mosteller & Tukey, 1977), which is not dependent on normality assumptions and 
less affected by extreme data. The outliers were identified based on the quartiles of the data. The 
distance between lower quartiles (Q1) and upper quartiles (Q3) was the inter quartile range (IQR). 
Any data point falling out of the range [Q1 – 1.5 IQR, Q3 + 1.5 IQR] was generally treated as a 
possible outlier, and any data point falling out of the range [Q1 – 3 IQR, Q3 + 3 IQR] was treated 
as a probable outlier. In this study, only probable outliers were excluded from the data set.  
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In addition, as the slices exposed to OGD were expected to undergo more severe biological 
damage than SHAM slices, any TTC experiments where OGD slices showed formazan 
absorbance higher, or equal to that of the associated control group were excluded from the final 
data set. Notably, if a data point for one of the three regions was removed, data points for the 
corresponding regions were also removed (to ensure that only complete sets were used). As a 
result of the previous a priori criteria, 3 of 12 male rats and 2 of 11 female rats were excluded 
from TTC assay results. 
3.8.3 Test for homogeneity of variances and normality  
To analyze effects among different groups, analysis of variance (ANOVA) is widely used. 
However, there are three assumptions that should be met before conducting an ANOVA. The 
first precondition is the independence of each sample group. Although slices from the three 
regions (septal hippocampus, temporal hippocampus, and motor cortex) were all prepared from 
the same rat brain, they were treated and tested separately, so the responses to OGD across the 
groups can be assumed to be independent. The other two preconditions are homogeneity of 
variance and the normality of the sample distribution. In our experiments, both the homogeneity 
of variance and the normality of distribution were tested before we assumed that the sample data 
met all the preconditions.  
Homogeneity of variance was tested to confirm that the expectation of random errors was 
equal to 0 (variances of each sample group were equal), so that the sample from each different 
group was statistically comparable. In this study, the Fligner-Killeen test was applied to test the 
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homogeneity of variances among different groups since the approach is a non-parametric test 
that doesn’t require the normal distribution assumption (Conover et al., 1981). If the result 
rejects the assumption of homogeneity of variances, transformations (such as logarithmic 
transformation,	   square root transformation, and	   reciprocal transformation) can be applied to 
adjust the homogeneity of variances, or a non-parametric test can be selected as an alternative to 
ANOVA. 
The normality of the sample distribution was also tested. As the sample size was small and 
the distribution of measures was unknown, the Shapiro-Wilk normality test (D'agostino et al., 
1990; Ghasemi & Zahediasl, 2012), which is ideal for small sample size (3 < N < 50), was 
conducted as the test for normality. To further assess the normality, graphical assessment (Q-Q 
plot) and an examination of the skewness and kurtosis were applied as well. If the data were 
normally distributed, the points in the Q-Q plot would lie on a straight diagonal line. Moreover, 
skewness close to zero indicated symmetry of the distribution. In general: (a)	   if skewness was 
less than -1 or greater than 1, the distribution was highly skewed, (b) if skewness was between -1 
and -0.5 or between 0.5 and 1, the distribution was moderately skewed, and (c) if skewness was 
between -0.5 and 0.5, the distribution was approximately symmetric. Similarly, kurtosis is 
another indicator about the height and sharpness of the central peak. In particular, kurtosis close 
to 0 indicated a normal distribution, kurtosis larger than 0 indicated a sharp peak, and kurtosis 
less than 0 indicated a flat peak to the distribution. 
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3.8.4 Two-way, mixed model ANOVA 
Since the tests described in the previous section supported that we could generally assume 
homogeneity of variance and normality of our sample distributions, the decision was made to 
select a parametric test to examine the differences among groups after OGD. In this study, the 
degree to which differences in OGD response were affected by two factors (sex and region) was 
uncertain In addition, one of the factors, region, consisted of measures from three brain areas 
(septal hippocampus, temporal hippocampus, and motor cortex) of each animal. As a result, a 
two-way, mixed ANOVA (with sex as the between subjects factor and region as the within 
subjects factor) was used to analyze the results. 
When evaluating the results, the possible interaction effects between sex and region were 
first considered. If the p < 0.05, there was an interaction, which could be further classified as 
ordinal (e.g., group means of one sex were always greater than the other sex among all regions), 
or disordinal (e.g.,	   two, or more group means switched, or crossed). When the data showed no 
significant interaction (p > 0.05), the potential main effects of sex and region were analyzed.  
3.8.5 Effect size calculation 
To quantify the strength of observed differences, an effect size was calculated as 
appropriate. Typically, eta-squared (η²) is widely used for effect size calculation for ANOVA. In 
addition, if repeated measures and/or multiple factors are involved, partial eta-squared (𝜂!!) can 
be used to better explain the effect from multiple variables (Lakens, 2013).  
In particular, 𝜂!! = 0.01 indicates a small magnitude of effect, 𝜂!! = 0.06 indicates a 
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moderate magnitude of effect, and 𝜂!!  = 0.14 indicates a large magnitude of effect. The 𝜂!!  was 
defined as the ratio of variance of an effect over that of the effect and the associated error 
variance，based on the following equation: 
 





𝑆𝑆!""!#$ = 𝑠𝑢𝑚  𝑜𝑓  𝑠𝑞𝑢𝑎𝑟𝑒  𝑓𝑜𝑟  𝑡ℎ𝑒  𝑒𝑓𝑓𝑒𝑐𝑡    𝑜𝑓  𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡; 
𝑆𝑆!""#" = 𝑠𝑢𝑚  𝑜𝑓  𝑠𝑞𝑢𝑎𝑟𝑒  𝑓𝑜𝑟  𝑡ℎ𝑒  𝑒𝑟𝑟𝑜𝑟  𝑡𝑒𝑟𝑚  𝑎𝑠𝑠𝑜𝑐𝑖𝑎𝑡𝑒𝑑  𝑤𝑖𝑡ℎ  𝑡ℎ𝑎𝑡  𝑒𝑓𝑓𝑒𝑐𝑡. 
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4. Results  
4.1 TTC assay 
4.1.1 Outliers 
Any TTC experiments where OGD slices showed formazan absorbance higher, or equal to 
that of the associated control group were excluded from the final data set. Based on the first 
criterion, 3 male rats and 2 female rats were excluded. In addition, data points for the 
corresponding regions were also removed to ensure that only complete data sets were used.  
Next, Tukey’s method was applied to identify probable outliers in the TTC assay dataset. 
Any data beyond the fences [Q1-3 IQR, Q3+3 IQR] of each group were removed from the data 
set. As noted in Table 7.1, there were no values beyond the fences. As a result, 9 of 12 male rats 
and 9 of 11 female rats were selected as the data set for further TTC assay analysis. 
4.1.2 Homogeneity of variances and normality  
The TTC results were tested for homogeneity of variances and normality of distribution 
(Table 7.2). In this dataset, the Fligner-Killeen test for homogeneity of variances was applied, 
and the interaction of multiple variables (e.g., sex, and region) was considered to adjust the 
degrees of freedom. The result (p = 0.21) showed no significant difference between the variances 
among the groups, so the TTC assay results were taken to have met the assumption of 
homogeneity of variance.  
Furthermore, the normality of the sampling distribution was tested (Table 7.2). In this study, 
the Shapiro-Wilk test was applied, as it is relatively optimal for small sample sizes (3 < N < 50). 
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All 6 groups, which were divided by sex and region (M-HP-S, M-HP-T, M-MCx, F-HP-S, 
F-HP-T, and F-MCx), were compared. In 4 of 6 groups, the null hypothesis regarding normality 
could not be rejected (p > 0.05, respectively), the remaining two groups (male temporal 
hippocampus (p = 0.04), and female septal hippocampus (p = 0.04), however, may not follow a 
normal distribution. Although different transformation methods could be used to adjust the raw 
data before further analysis, since the p values were close to the 0.05 threshold the assumption 
could be made that the departure from normality was not excessive.  
To further assess normality, graphical assessment (Q-Q plot) and an examination of the 
skewness and kurtosis were applied. If the data were normally distributed, the points in a Q-Q 
plot would lie on a straight diagonal line. According to Figure 7.5, besides the Q-Q plots of male 
temporal hippocampus and female septal hippocampus, all others resembled a straight line, 
which parallels the Shapiro-Wilk test results.  
Moreover, skewness and kurtosis were assessed. In general,	  if skewness was less than -1, or 
greater than 1, the distribution was highly skewed. The skewness value of the female septal 
hippocampus group (-1.093) indicated that the distribution might be right skewed (Table 7.2). 
Kurtosis describes the height and sharpness of the central peak; in particular, kurtosis close to 0 
indicates a normal distribution. The most extreme kurtosis value (-1.959) was found for the male 
temporal hippocampus group, and indicated that the distribution curve might be relatively flat. 
The assessment tests indicated that the variances of the TTC data were homogeneous, and 
that, with the exception of the male temporal hippocampus and female septal hippocampus 
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groups, the TTC data could be assumed to have followed a normal distribution. Lastly, the data 
from the different slice groups (M-HP-S, M-HP-T, M-MCx, F-HP-S, F-HP-T, and F-MCx) were 
treated as independent samples. Given that linear models are able to withstand modest deviations 
from normality (Khan & Rayner, 2003), the decision was made to apply a two-way, mixed 
model ANOVA to analyze the TTC assay data. 
4.1.3 TTC metabolism in the OGD model  
According to Figure 7.8A, the slice preparation protocol induced little injury to the slices. 
After a 3-hour reperfusion, the control slices were very clearly metabolically active. In contrast, 
the 10 min OGD challenge significantly interfered with mitochondrial function to varying 
degrees.  
4.1.4 Region and sex differences in the TTC assay after OGD challenge  
To evaluate region and sex-based differences, the formazan absorbance values of OGD 
groups were taken as a percent of the corresponding control groups. According to the TTC assay, 
after a 3 h recovery following 10 min OGD, the male septal hippocampus, temporal 
hippocampus, and motor cortex slices underwent declines of 53.2%, 43.2%, and 51.9% in 
metabolism, and the female septal hippocampus, temporal hippocampus, and motor cortex slices 
underwent declines of 59.2%, 57.2%, and 38.1% in metabolism (Table 7.2; Figure 7.8).  
In this study, sex was a between-subjects variable, and region was a within-subjects variable 
(i.e., a repeated, or matched measure); as well, the interaction between sex and region were 
considered. According to Figure 7.8B and Table 7.3, there was not a significant interaction 
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between sex and region (p = 0.84, F(2,48) = 0.17). 
Although examining the means alone would suggest that the septal hippocampal slices 
seemed to be the most vulnerable in both male and female rats, there was no significant main 
effect of region (p = 0.34, F(2,48) = 1.11) (Figure 7.8C; Table 7.3). While the male and female 
slices appeared to differ in their vulnerability, there was no significant main effect of sex (p = 
0.62, F(1,48) = 0.24) (Figure 7.8D; Table 7.3). 
4.1.5 Magnitude of the differences 
In order to evaluate the magnitude of the observed differences, effect sizes (𝜂!!) were 
calculated. In particular, 𝜂!! = 0.01 indicates a small magnitude of effect, 𝜂!! = 0.06 indicates a 
moderate magnitude of effect, and 𝜂!!  = 0.14 indicates a large magnitude of effect. Based on the 
results (Table 7.3), the magnitude of the sex difference was very small (𝜂!! = 0.002   < 0.01), 
and the magnitude of the regional difference was between small and medium (0.01 < 𝜂!! =
0.04   < 0.06). In addition, the strength of the interaction effect between sex and region was of a 
medium magnitude (𝜂!! = 0.06) (Table 7.3). 
4.2 Immunoblot analysis 
4.2.1 Outliers 
In this study, 5 male and 5 female rats were used to analyze surface expression of GluA1 
and GluA2 subunits. As with the TTC data, Tukey’s method was applied to identify probable 
outliers. Any data beyond the fences [Q1 - 3 IQR, Q3 + 3 IQR] of each group were considered 
outliers. According to Table 7.4 and Table 7.7, there were 5 extreme values beyond the fences. 
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Common methods to deal with the outliers, but not to influence sample size, include assigning 
new estimated values (e.g., the mean value for the rest of the observations, or predicted values by 
a regression model), or trying a transformation (e.g., log-transform, or square-root transform) 
(Khan & Rayner, 2003; Cousineau & Chartier, 2010; Bakker & Wicherts, 2014; Kwak & Kim, 
2017; Pollet & Meij, 2017). However, as ANOVA is relatively robust to violations of normality 
(Khan & Rayner, 2003), a two-way, mixed model ANOVA was used for data analysis without 
the removal of outliers. 
4.2.2 Homogeneity of variances and normality  
According to the immunoblot results, the optical density of surfaced expressed GluA1 and 
GluA2 were detected and analyzed, and specifically, the optical density of OGD groups was 
taken as a percent of the corresponding control groups. The Fligner-Killeen test showed no 
significant differences among the variances of the different groups for the surface expression of 
both GluA1 (p = 0.68, Table 7.5) and GluA2 (p = 0.52, Table 7.8), which indicated that the 
immunoblot results met the assumption of homogeneity of variance.  
Furthermore, the normality of the distribution was tested. The Shapiro-Wilk test was 
applied, and p-values in all groups were larger than 0.05, except in male temporal hippocampus 
group (p = 0.006 for GluA1, and p = 0.006 for GluA2, Tables 7.5 and 7.8). If p > 0.05, the null 
hypothesis could not be rejected, indicating the immunoblot results followed a normal 
distribution. If p < 0.05, the null hypothesis should be rejected. However, as discussed above, 
ANOVA is relatively robust to violations of the normality assumption, and may still be applied 
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even if not all data follow a normal distribution. 
To further assess the normality, graphical assessment (Q-Q plot) and an examination of the 
skewness and kurtosis were applied as well. As noted previously, if the data were normally 
distributed, the points in a Q-Q plot would lie on a straight diagonal line. According to Figure 7.6 
and Figure 7.7, although the sample size is relatively small (N = 5), all Q-Q plots demonstrated 
patterns similar to a straight line, which tended to indicate normal distribution. 
Moreover, skewness close to zero indicated symmetry of the distribution. According to the 
GluA1 (Table 7.5) and GluA2 (Table 7.8) immunoblot results, the skewness value indicated that 
the distribution of all groups might be skewed to varying degrees. Kurtosis is another indicator 
about the height and sharpness of the central peak. In particular, kurtosis close to 0 indicates a 
normal distribution, kurtosis larger than 0 indicates a sharp peak, and kurtosis less than 0 
indicates a flat peak of distribution. According to the immunoblot results for GluA1 (Table 7.5), 
the kurtosis values indicated that the distribution curve might be relatively sharp in all groups 
except the female motor cortex group (-0.792). According to the immunoblot results for GluA2 
(Table 7.8), the kurtosis values indicated that the distribution curve might be relatively sharp in 
all groups except the female temporal hippocampus group (-0.833). 
In summary, since the diagnostic tests indicated that both the GluA1 and GluA2 
immunoblot data tended to follow a normal distribution and the variances were homogeneous, a 
two-way, mixed model ANOVA (with sex as the between subjects variable) was applied to 
analyze the data. 
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4.2.3 GluA1 surface expression after OGD challenge 
According to the immunoblot data of male rats, the surface expression of GluA1 underwent 
a 43.9% increase in septal hippocampal slices, a 13.5% decrease in temporal hippocampal slices, 
and a 4.2% decrease in motor cortex slices (Figure 7.9). In contrast, the female data showed a 
32.2%, 20.9%, and 0.4% increase of GluA1 surface expression in septal, temporal hippocampus, 
and motor cortex slices, respectively (Figure 7.9).  
To determine the presence of regional and sex differences in GluA1 surface expression after 
OGD challenge, a two-way, mixed model ANOVA was conducted. Although it seemed that 
disordinal interaction effect might exist between sex and region (Figure 7.9B), the interaction 
effect was not significant (p = 0.41, F(2,21) = 0.934), and there was no significant effect of either 
region (p = 0.91, F(2,21) = 0.096), or sex (p = 0.21, F(1,21) = 1.71) on GluA1 surface expression 
after 10 min OGD. The data indicated that OGD-mediated changes in GluA1 surface expression 
of male and female rats were not significantly different among the regions examined after OGD 
(Table 7.6; Figure 7.9). 
4.2.4 Region and sex difference of GluA2 surface expression after OGD challenge  
According to the immunoblot data, within the septal hippocampus, OGD caused the surface 
expression of GluA2 to undergo a 15.1% increase in male rats, and a 51.3% increase in female 
rats. In contrast, GluA2 surface expression decreased 9.5% in male temporal slices, but increased 
23.1% in female temporal slices. In motor cortex, GluA2 surface expression decreased more in 
male (15.6%) than female (4.0%) slices (Figure 7.10). 
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To examine regional and sex differences in GluA2 surface expression after 10 min of OGD, 
a two-way, mixed model ANOVA was conducted (Table 7.9; Figure 7.10). In this study, there 
was no significant interaction between sex and region (p = 0.11, F(2,21) = 2.40). In addition, there 
was no significant effect of either region (p = 0.98, F(2,21) = 0.020), or sex (p = 0.14, F(1,21) = 2.33) 
on GluA2 surface expression after 10 min OGD. The data indicated that OGD-mediated changes 
in GluA2 surface expression of male and female rats were not significantly different among the 
regions examined after OGD (Table 7.9; Figure 7.10). 
4.2.5 Magnitude of the differences 
In order to evaluate the magnitude of the observed differences, effect sizes (𝜂!!) were 
calculated. As noted, 𝜂!!  = 0.01 indicates small magnitude of effect, 𝜂!!  = 0.06 indicates 
moderate magnitude of effect, and 𝜂!!  = 0.14 indicates large magnitude of effect. Based on the 
GluA1 results (Table 7.6), the magnitude of the sex difference was small (𝜂!! = 0.015), and the 
magnitude of the regional difference was between small and medium (0.01 < 𝜂!! = 0.043 <
  0.06). In addition, the strength of the interaction effect between sex and region (0.06 < 𝜂!! =
0.081 < 0.14) was calculated as well, and was observed to have a medium to large magnitude. 
Similarly, the magnitude of sex and regional differences of GluA2 surface expression 
alteration were calculated (Table 7.9). The magnitude of the sex difference was medium to large 
(0.06 < 𝜂!! = 0.088 <   0.14), and the magnitude of the regional difference was between small 
and medium (0.01 < 𝜂!! = 0.026 < 0.06). In addition, the strength of the interaction effect 
between sex and region (0.01 < 𝜂!! = 0.044 < 0.06) was small to medium.  
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5. Discussion  
In this study, the effect of an established in vitro model of ischemia (OGD, oxygen-glucose 
deprivation) on tissue slices prepared from rat hippocampus and motor cortex was examined. In 
addition, possible sex differences after ischemia were examined by using tissue slices from both 
male and female rats. A 2,3,5- Triphenyltetrazolium Chloride (TTC) Assay was used to measure 
mitochondrial function for slice viability comparisons (Lalonde & Mielke, 2014). In addition, 
Sulfo-NHS-SS-biotin (Blanco-Suarez & Hanley, 2014) was used to label surface expressed 
proteins, and the amount of targeted surface GluA1 and GluA2 subunits was identified with 
SDS-PAGE and immunoblotting to determine GluA1 and GluA2 surface expression among the 
different sample groups.  
According to the TTC assay data, although it was hypothesized that the hippocampal slices 
would be more vulnerable than motor cortex slices after a 3 h recovery following 10 min OGD, 
the results were not consistent with the hypothesis, and motor cortex slices even seemed to be 
more vulnerable than hippocampal slices in female rats. Furthermore, within the hippocampus, 
the septal pole slices were expected to be more vulnerable than the temporal pole slices, which 
agreed with the general pattern of the current findings, however, according to the TTC assay 
result, after a 3 h recovery following 10 min OGD, there was no significant interaction effect 
between sex and region, and no significant main effect of region or sex. 
Similarly, the surface expression of GluA2 was expected to decrease in all groups and in a 
manner that paralleled slice viability. However, according to the comparisons, although GluA2 
	   37	  
surface expression decreased a bit in motor cortex, surface expression of GluA2 increased in 
both septal and temporal hippocampal slices, and there was no sex-region interaction and no 
significant main effect of region or sex. 
In addition, based on the calculated effect size (partial eta-squared, ηp2), the TTC assay 
showed that the strength of the interaction effect between sex and region was of a medium 
magnitude, the magnitude of the sex difference in metabolic function was very small, and the 
magnitude of the regional difference was between small and medium. In addition, the surface 
expression of GluA2 showed that the strength of the interaction effect between sex and region, 
and the magnitude of the regional difference were small to medium, and the magnitude of the sex 
difference was medium to large. As a result, the sex difference of GluA2 surface expression 
might be notable, but none of the magnitudes of difference were large (ηp2	  = 0.14 indicates a 
large magnitude of effect). 
In summary, the alterations of metabolic function and surface expression of GluA2 were not 
significantly different between cortical and hippocampal slices in either male, or female rats, 
after a 10 min OGD challenge. 
5.1 2,3,5 - Triphenyltetrazolium chloride (TTC) assay and cell viability 
According to our results, 10 min of OGD followed by 3 h of recovery lead to a 40% - 60% 
decrease of TTC metabolism across groups, which was considered a moderate level of injury. 
Furthermore, it seemed that hippocampal slices from male rats were more robust than those from 
female rats, and motor cortex slices were more robust in female rats. In addition, within 
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hippocampus, septal pole slices appeared more vulnerable than temporal pole slices from both 
male and female rats. However, the sex and region-based differences in viability were not 
statistically significant, which conflicted with the hypotheses. 
One possible reason for a significant sex, or region difference not being detected via the 
TTC assay could be the relatively large systemic variability of the methodology, which may lead 
to large standard error of means (SEM). According to the hippocampal data, the trend showed 
that septal slices were more vulnerable than temporal slices in both male and female rats, which 
paralleled the assumptions, but the difference was not statistically significant. This outcome may 
be due to the high standard error of means (SEM) of the TTC assay data. During the TTC assay 
process, each group had 3 technical replicate slices and the average formazan absorbance was 
used to measure the concentration of the 1,3,5- triphenylformazan (TPF), which reflects the 
metabolism level of slices after OGD. Once control slices turned out to be not viable during the 
experiments, which was common and unpredictable (around 30% of the experiments), the faded 
slices were noticeably lighter than the others and could significantly affect the results in terms of 
viability. One possible solution would be to increase technical replicates in each slice group, 
however, this is restricted by the size of hippocampus and the slicing protocol. As a result, 
although TTC metabolism is one proxy for cell viability, it may not be sensitive enough to detect 
the existing differences, and an alternative method, such as recording field potentials, may be 
needed as a supplement. 
In addition, the TTC assay was conducted 3 hours after OGD, and was expected to measure 
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the early stage of mitochondrial dysfunction. However, delayed mitochondrial dysfunction and 
cell death may be still on going and not completed at that time point. As a result, the possible 
difference may not be apparent within the first 3 h following injury. For example, HSPB8 (heat 
shock protein B8), which protects cells by inhibiting the mitochondrial apoptotic pathway, was 
overexpressed after OGD, but a statistically significant upregulation can be detected only after 4 
hours of reperfusion, not after 1 hour of reperfusion (Li et al., 2018). However, it may not be 
feasible to simply lengthen the reperfusion time to 24 - 72 hours (as done in cell culture studies) 
before conducting the TTC assay. Unlike in vitro neuronal cell culture methods that can be kept 
for days to weeks, the brain slice model can only remain	   functionally active for several hours 
before further degeneration (Mielke et al., 2007), which limits the ability of the methodology to 
measure late cell viability differences.  
5.2 Biotinylation and surface expression of GluA1 & GluA2 
According to the immunoblot data, after 10 min of OGD, surface expression of GluA1 was 
altered across the groups. For example, both male and female rats underwent GluA1 
up-regulation in septal hippocampal slices; temporal hippocampal slices, however, underwent 
surface GluA1 down-regulation in male rats and up-regulation in female rats, and GluA1 
expression was relatively unchanged in both male and female motor cortex slices. However, 
there was no significant sex and region interaction, or main effect of sex, or region among the 
different groups. 
The surface expression data of GluA2 showed neither a significant sex-region interaction, 
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nor a significant main effect of sex, or region. The increase of GluA2 surface expression in septal 
hippocampal slices seemed greater in female slices; the GluA2 surface expression in temporal 
hippocampal slices decreased in male rats, but increased in female rats, and the GluA2 surface 
expression in motor cortex slices was down-regulated more in male than in female slices. 
Although a two-way, mixed model ANOVA showed no significant differences, the magnitude of 
the sex difference was medium to large, which might be notable. To further explore the specific 
sex difference among different regions, a t test was applied between male and female groups, in 
the three individual region groups. The results showed that within temporal hippocampal slices, 
GluA2 surface alteration after OGD was significantly different between male and female rats. 
However, there was no significant difference of GluA2 surface alteration between male and 
female rats in septal hippocampus and motor cortex, after 10 min of OGD. 
The results did not parallel the work of Blanco-Suarez and Hanley (2014). According to 
their neuronal culture work, after 20 min of OGD, biotinylation showed that GluA1 was 
relatively stably inserted at the plasma membrane in both cortical and hippocampal neurons, and 
GluA2 was internalized in hippocampal neurons, but not in cortical neurons. In addition, in a 
recent study, it was detected that the internalization of GluA2 induced by OGD was due to the 
endocytosis of GluA2/3, but not GluA1/2 receptors (Koszegi et al., 2017). 
One possible reason for the inconsistency may be the disparity among different 
experimental models. Notably, the hippocampal neurons for the culture work were extracted 
from CA1 region (Dennis et al., 2012; Blanco-Suarez and Hanley, 2014), which is thought to be 
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the most vulnerable sub-region to ischemic injury within hippocampus (Dennis et al., 2012; 
Butler et al., 2011; Kass & Lipton, 1986), but the acute slice model utilizes slices containing all 
sub-regions. As a result, further study with sub-region (e.g., CA1) specific slices can be 
conducted to allow for a more direct comparison with the culture work; however, by removing 
DG and/or CA3, the reduced size of the slices may lead to a lower total protein level, which may 
make measuring surface expressed proteins difficult. 
In addition, the slice model may still not be accurate enough to explain some 
multi-mechanism-affected alterations. For example, sex-specific responses to OGD could be 
mediated by	  hormone level alteration, which is, however, identical within current slice models. 
As the GluA2 surface expression affected by sex showed a moderate to large magnitude in this 
study, further experiments should be considered to better control sex-related variables to identify 
the underlying mechanisms. For example, the menstrual cycle of female rats can be tested to 
correlate with GluA2 surface expression alteration after OGD. 
In this study, surface expression of GluA1 and GluA2 was detected right after 10 min OGD, 
without reperfusion. This design was based on the findings (Blanco-Suarez & Hanley, 2014) that 
surface expression alteration persists from 0 - 3 hours. However, according to our current results, 
the phenomenon may vary between culture and slice work. Further study could be designed to 
harvest slices after different lengths of reperfusion time and compare the surface expression 
alteration over time.  
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5.3 Future directions 
In this study, brain slices were prepared from young adult rats. As stroke naturally has 
higher prevalence among older populations, some concerns about the differences between young 
adult brains and aging brains may be considered. In particular, both the basal level of AMPA 
receptors and the modifications of AMPA receptors after injury could be age-dependent 
(Montori et al., 2010; Wenk & Barnes, 2000). For example, according to an in vivo study from 
Montori et al. (2010), GluA1 mRNA level was higher in hippocampus, but not in cerebral cortex, 
and GluA2 mRNA levels was higher in both hippocampus and cerebral cortex, in the aged rats 
(18-month-old) than in young rats (3-month-old), at the basal level (before ischemia). After 
transient global ischemia, a down-regulation of GluA1 and GluA2 mRNA levels was observed in 
both young and aged rats, but was milder in the older group (Montori et al., 2010). The 
age-dependent alteration pattern of AMPA receptor subunit expression suggests that using young 
adult rats might not be ideal to estimate the AMPA receptor trafficking mechanism after OGD. 
Further experiments completed with older rats could be done to identify the possible AMPA 
receptor trafficking mechanisms. 
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6. Conclusion  
According to the existing literature, ischemic stroke outcome may vary due to different 
factors. Although, in general, the brain is vulnerable to ischemic stroke, regional differences 
between hippocampus and motor cortex exist. In addition, the functionally different structures 
along the longitudinal axis of the hippocampus may display regional vulnerability. As well, it is 
also possible to observe sexual dimorphism after OGD, which may be regulated by sex hormone 
levels and other cellular-level factors.  
Data have shown that with the current acute slice OGD model, the recoverable ischemic 
effect is well simulated. With the TTC assay data, regional and sex differences in mitochondrial 
function after OGD, are not statistically significant, which may be due to the relatively small 
sample size and small effect size. In addition, based on the surface expression data, a sex 
difference exists in GluA2 surfaces expression after OGD, and sex-region interaction exists in 
GluA1 surface expression after OGD. Further study that can determine synapse specific AMPA 
receptor alterations after OGD is needed to explore the trafficking mechanisms, and to 
understand the different role of hippocampus (septal vs. temporal) and motor cortex in the 
response to OGD between male and female rats. 
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Figure 7.1 Slice preparation. A)	  The schematic illustrates how samples were assigned to collect 
hippocampal and motor cortex slices. B) Hippocampal slice preparation. C)	  Motor cortex slice 
preparation. Figure adapted from “The Rat Brain in Stereotaxic Coordinates: Compact 7th 
Edition” by Paxinos, G., & Watson, C., 2017, Academic Press. (57). The lines in each plate 
denote the region from each slice that was taken as the motor cortex.  
A	   B	  
C	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Figure 7.2 Tissue assignment across experimental groups. The schematic illustrates how 
tissue slices were collected and assigned to each group.  
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Figure 7.3 Summary of experimental protocol. The experimental process to generate the in 
vitro OGD challenge, TTC assay, and biotinylation.  
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Figure 7.4 The process of biotinylation. The experimental process to generate 
bead-biotin-protein complexes samples for SDS-PAGE. 
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Figure 7.5 Q-Q plots of the TTC data. In this set of figures, the values of x-axis present the 
theoretical quantiles, and the values of y-axis present the actual sample quantiles. If the data 
were normally distributed, the points in the Q-Q plot would lie on a straight diagonal line.  
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Figure 7.6 Q-Q plots of the GluA1 immunoblot results. In this set of figures, the values of 
x-axis present the theoretical quantiles, and the values of y-axis present the actual sample 
quantiles. If the data were normally distributed, the points in the Q-Q plot would lie on a straight 
diagonal line.  
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Figure 7.7 Q-Q plots of the GluA2 immunoblot results. In this set of figures, the values of 
x-axis present the theoretical quantiles, and the values of y-axis present the actual sample 
quantiles. If the data were normally distributed, the points in the Q-Q plot would lie on a straight 
diagonal line.  
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Figure 7.8 TTC assay result showed	  no significant sex or region difference in metabolic 
activity after OGD. A) Representative images of TTC assay results in one male rat. In both the 
septal and temporal regions, mitochondrial metabolism of TTC was significantly reduced after a 
3 h recovery from 10 min of OGD. B) Although there appeared to be a disordinal sex-region 
interaction, the interaction was not statistically significant, p = 0.84, F(2,48) = 0.17 C) The main 
effect of sex was compared. The male and female septal hippocampal slices underwent declines 
of 53.2%	 ± 7.38% and 59.2% ± 7.01% in metabolism; the male and female temporal 
hippocampal slices underwent declines of 43.2% ± 11.8% and 57.2% ± 5.79% in metabolism; 
the male and female motor cortex slices underwent declines of 51.9% ± 10.0% and 38.1% ± 7.38% 
in metabolism. N = 9. D) The main effect of region was compared. The male septal and temporal 
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hippocampal slices, and motor cortex slice underwent declines of 53.2%	 ± 7.38%, 43.2% ± 
11.8%, 51.9% ± 10.0%, respectively; and the female septal and temporal hippocampal slices, and 
motor cortex slice underwent declines of 59.2% ± 7.01%, 57.2% ± 5.79%, 38.1% ± 7.38% 51.9% 
± 10.0%, respectively. N = 9. Data are presented as mean ± S.E.M.   
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Figure 7.9 Immunoblot result showed no significant sex or region difference in GluA1 
surface expression after OGD. A) Representative immunoblot images of GluA1 surface 
expression in one male and one female rat. B) There was no significant interaction effect, no 
significant sex, or region difference in GluA1 surface expression, based on the two-way, mixed 
ANOVA results. GluA1 surface expression alteration ratios (presented as a percent of SHAM) 
increased 43.9% ± 48.94% in septal hippocampal slices, and decreased 13.52% ± 19.01%, and 
A	  
B	   D	  
C	   E	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4.22% ± 6.95% in temporal hippocampal slices, and motor cortex slices, respectively, after OGD 
in male rats. N = 5. GluA1 surface expression alteration ratios (presented as a percent of SHAM) 
increased 32.1% ± 20.2%, 20.9 % ± 1.41%, and 0.34% ± 12.58 % in septal hippocampal slices, 
temporal hippocampal slices, and motor cortex slices, respectively, after OGD in female rats. N = 
5. C) The box plot for GluA1 surface expression. D) The main effect of sex was compared. E) 
The main effect of region was compared. % of GluA1 alteration ratio 
=!"#$!  !"#$!%%&'(  !"  !"#  !"#$%  
!"#$!  !"#$!%%&'(    !"  !"#$
×100%− 100%. Data are presented as mean ± S.E.M.   
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Figure 7.10 Immunoblot result showed no significant sex or region difference in GluA2 
surface expression after OGD. A) Representative immunoblot images of GluA2 surface 
expression in one male and one female rat. B) There was no significant interaction effect, no 
significant sex, or region difference in GluA2 surface expression, based on the two-way, mixed 
ANOVA results. GluA2 surface expression alteration ratios (presented as a percent of SHAM) 
increased 15.1 % ± 34.0 % in septal hippocampal slices, and decreased 8.47 % ± 6.38 %, and 
A	  
B	   C	  
D	   E	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15.6% ± 3.93% in temporal hippocampal slices, and motor cortex slices, respectively, after OGD 
in male rats. N = 5. GluA1 surface expression alteration ratios (presented as a percent of SHAM) 
of female rats (presented as a percent of SHAM) increased 51.3 % ± 33.4 %, and 23.1 % ± 3.30% 
in septal hippocampal slices, and temporal hippocampal slices, and decreased 4.00% ± 12.3% in 
Motor cortex slices, after 10 min OGD. N = 5. C) The box plot for GluA2 surface expression. D) 
The main effect of sex was compared. E) The main effect of region was compared. % of GluA2 
alteration ratio =!"#$!  !"#$!%%&'(  !"  !"#  !"#$%  
!"#$!  !"#$!%%&'(    !"  !"#$
×100%− 100%.Data are presented as mean ± 
S.E.M.  
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 Male  Female 
HP-S HP-T MCx HP-S HP-T MCx 
Q1 0.333 0.156 0.207 0.368 0.317 0.471 
Q3 0.632 0.883 0.669 0.549 0.472 0.767 




(Q1 - 3 IQR) -0.564 -2.025 -1.179 -0.175 -0.148 -0.417 
Max value 
(Q3 + 3 IQR) 1.529 3.064 2.055 1.092 0.937 1.655 
No. of Outlier(s) 0 0 0 0 0 0 
Table 7.1 TTC assay outlier test results. Q1, lower quartiles; Q3, upper quartiles; IQR, inter 
quartile range; HP-S, septal hippocampus; HP-T, temporal hippocampus; MCx, motor cortex. 
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 Male Female 
N 9 9 
Fligner-Killeen test (p value) 0.209 
HP-S Mean % SHAM  46.8% 40.1% 
SEM 7.38% 7.01% 
Shapiro-Wilk test (p value) 0.653 0.0367 * 
Skewness 0.500 -1.093  
Kurtosis 0.0714 -0.205 
HP-T Mean % SHAM 56.8% 42.8% 
SEM 11.9% 5.79% 
Shapiro-Wilk test (p value) 0.0363 * 0.938 
Skewness -0.453 0.392 
Kurtosis -1.959 0.202 
MCx Mean % SHAM 48.1% 61.9% 
SEM 10.0% 7.38% 
Shapiro-Wilk test (p value) 0.259 0.133 
Skewness 0.329 -0.807 
Kurtosis -1.533 -0.891 
Table 7.2 Assessment of homogeneity of variance and distribution characteristics for the 
TTC data. Data presented as % of SHAM TTC formazan absorbance. Standard error of the 
mean (SEM) was calculated for each group. Homogeneity of variances across the groups was 
determined by the Fligner-Killeen test, and the assumption of homogeneity of variance could not 
be rejected. Normality of distributions for the groups was examined by the Shapiro-Wilk test, 
and the assumption of normality might not be accepted in the female septal hippocampus group 
and the male temporal hippocampus group, *, p value < 0.05. Skewness and kurtosis were also 
calculated to evaluate normality.	   Skewness less than -1, or greater than 1 indicates a highly 
skewed distribution, while kurtosis close to 0 indicates a normal distribution. 
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p value 𝜼𝒑𝟐 
Sex 0.244 1 0.0159  0.0159 0.624 0.00223 
Region 1.113 2 0.145  0.0726 0.337 0.0373 
Sex: 
Region 
0.172 2 0.0224  0.0112 0.843 0.0565 
Residuals NA 45 2.935  0.0652 NA NA 
Table 7.3 Summary of two-way, mixed model ANOVA results for the TTC assay data. 
There was no significant sex-region interaction in metabolic activity after OGD. As well, there 
were no significant sex, or region-based differences in metabolic activity after OGD. 
Interpretation of effect sizes measured by 𝜂!! is as follows: Small, 𝜂!! = 0.01, medium, 𝜂!!  = 
0.06, large, 𝜂!! = 0.14. df, degree of freedom. 
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GluA1 Male  Female 
HP-S HP-T MCx HP-S HP-T MCx 
Q1 0.772 0.629 0.934 1.158 0.838 1.208 
Q3 1.541 1.576 1.056 1.238 1.145 1.676 




(Q1 - 3 IQR) -1.536 -2.214 0.569 0.236 0.918 -0.081 
Max value 
(Q3 + 3 IQR) 3.850 4.419 1.421 2.487 1.478 2.065 
Rat No. of Outlier(s) 0 1  0 0 2 0 
Table 7.4 Outlier results for the immunoblot data of GluA1 surface expression. The outliers 
were identified by Tukey’s methods. The fence used to identify outliers was (Q1 – 3 IQR, Q3 + 3 
IQR). Temporal hippocampal data from rat male 4, female 1, and female 2 were classified as 
outliers. Q1, lower quartiles; Q3, upper quartiles; IQR, inter quartile range; HP-S, septal 
hippocampus; HP-T, temporal hippocampus; MCx, motor cortex.  
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 Male Female 
N 5 5 
Fligner-Killeen test (p value) 0.679 
HP-S Mean % SHAM 144% 132% 
SEM 48.9% 20.2% 
Shapiro-Wilk test (p value) 0.515 0.945 
Skewness 1.163 -0.0491 
Kurtosis 1.767 0.668 
HP-T Mean % SHAM  206% 129% 
SEM 121.2% 16.6% 
Shapiro-Wilk test (p value) 0.006 * 0.190 
Skewness 2.105 1.462 
Kurtosis 4.486  3.076 
MCx Mean % SHAM 95.8% 100% 
SEM 6.95% 12.6% 
Shapiro-Wilk test (p value) 0.141 0.6144 
Skewness -1.615 -0.694 
Kurtosis 2.482 -0.792 
Table 7.5 Assessment of homogeneity of variance and distribution characteristics for the 
immunoblot data of GluA1 surface expression Data presented as % of SHAM. Standard error 
of the mean (SEM) was calculated for each group. Homogeneity of variances for GluA1 surface 
expression was test by the Fligner-Killeen test, and the assumption of homogeneity of variances 
could not be rejected. Normality of distribution for GluA1 surface expression was test by the 
Shapiro-Wilk test, and the assumption of normality could not be rejected, except in the male 
temporal hippocampus group, *, p value < 0.05. Skewness and kurtosis were also calculated to 
evaluate normality.	   Skewness less than -1, or greater than 1 indicates a highly skewed 
distribution, while kurtosis close to 0 indicates a normal distribution.  
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p value 𝜼𝒑𝟐 
Sex 1.709 1 3.55 3.547 0.205 0.048 
Region 0.096 2 0.40 0.198 0.909 0.011 
Sex: 
Region 
0.934 2 3.88 1.939 0.409 0.015 
Residuals NA 21 43.58 2.075 NA NA 
Table 7.6 Summary of two-way, mixed model ANOVA results for the immunoblot results 
of GluA1 surface expression. There was no significant sex-region interaction in metabolic 
activity after OGD. As well, there were no significant sex, or region-based differences in 
metabolic activity after OGD. Interpretation of effect sizes measured by 𝜂!! is as follows: Small, 
𝜂!! = 0.01, medium, 𝜂!!  = 0.06, large, 𝜂!! = 0.14. df, degree of freedom.  
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GluA2 Male  Female 
HP-S HP-T MCx HP-S HP-T MCx 
Q1 0.656 0.873 0.836 1.208 1.188 0.842 
Q3 1.294 1.048 0.973 1.676 1.277 1.022 




(Q1 - 3 IQR) -1.258 0.350 0.425 -0.196 0.920 0.302 
Max value 
(Q3 + 3 IQR) 3.207 1.571 1.383 3.081 1.545 1.561 
Rat No. of Outlier(s) 0 1 1 0 0 0 
Table 7.7 Outlier results for the immunoblot data of GluA2 surface expression. The outliers 
were identified by Tukey’s methods. The outlier fence used to identify outliers was (Q1 – 3 IQR, 
Q3 + 3 IQR). Temporal hippocampus and motor cortex data from rat male 4 were classified as 
outliers. Q1, lower quartiles; Q3, upper quartiles; IQR, inter quartile range; HP-S, septal 
hippocampus; HP-T, temporal hippocampus; MCx, motor cortex. 
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 Male Female 
N 5 5 
Fligner-Killeen test (p value) 0.523 
HP-S Mean % SHAM 115% 151% 
SEM 34.0% 33.4% 
Shapiro-Wilk test (p value) 0.590 0.610 
Skewness 1.101 1.057 
Kurtosis 1.372 1.645 
HP-T Mean % SHAM 136% 123% 
SEM 45.5% 3.30% 
Shapiro-Wilk test (p value) 0.006* 0.245 
Skewness 2.125 -0.972 
Kurtosis 4.625 -0.833 
MCx Mean % SHAM  95.8% 96.0% 
SEM 12.1% 12.3% 
Shapiro-Wilk test (p value) 0.137 0.410 
Skewness 1.675 1.263 
Kurtosis 3.022 1.766 
Table 7.8 Assessment of homogeneity of variance and distribution characteristics for the 
immunoblot data of GluA2 surface expression Data presented as % of SHAM. Standard error 
of the mean (SEM) was calculated for each group. Homogeneity of variances for GluA2 surface 
expression was test by the Fligner-Killeen test, and the assumption of homogeneity of variances 
could not be rejected. Normality of distribution for GluA2 surface expression was test by the 
Shapiro-Wilk test, and the assumption of normality could not be rejected except in the male 
temporal hippocampus group, *, p value < 0.05. Skewness and kurtosis were also calculated to 
evaluate normality.	   Skewness less than -1, or greater than 1 indicates a highly skewed 
distribution, while kurtosis close to 0 indicates a normal distribution.  
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p value 𝜼𝒑𝟐 
Sex 2.325 1 3.499 3.499 0.142 0.042 
Region 0.020 2 0.061 0.030 0.980 0.010 
Sex: 
Region 
2.398 2 7.218 3.609 0.115 0.055 
Residuals NA 21 31.605 1.505 NA NA 
Table 7.9 Summary of two-way, mixed model ANOVA results for the immunoblot results 
of GluA2 surface expression. There was no significant sex-region interaction in metabolic 
activity after OGD. As well, there were no significant sex, or region-based differences in 
metabolic activity after OGD. Interpretation of effect sizes measured by 𝜂!! is as follows: Small, 
𝜂!! = 0.01, medium, 𝜂!!  = 0.06, large, 𝜂!! = 0.14. df, degree of freedom.  
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p value (adjusted) GluA1 GluA2 
female,hps - male,hps 0.999 0.996 
female,hps - female,hpt 0.999 0.999 
female,hps - male,hpt 0.959 0.966 
female,hps - female,mcx 0.992 0.955 
female,hps - male,mcx 0.943 0.946 
male,hps - female,hpt 0.998 0.999 
male,hps - male,hpt 0.907 0.999 
male,hps - female,mcx 0.966 0.766 
male,hps - male,mcx 0.983 0.998 
female,hpt - male,hpt 0.987 0.998 
female,hpt - female,mcx 0.999 0.821 
female,hpt - male,mcx 0.879 0.995 
male,hpt - female,mcx 0.999 0.581 
male,hpt - male,mcx 0.562 0.999 
female,mcx - male,mcx 0.709 0.523 
Table 7.10 Post-hoc test (Tukey’s test) for immunoblot analysis. There is no significant 
between-group difference of GluA1 and/or GluA2 surface expression after OGD, *, Tukey’s test, 
p < 0.05. 
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